233 related articles for article (PubMed ID: 23326436)
1. Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.
Minion J; Gallant V; Wolfe J; Jamieson F; Long R
PLoS One; 2013; 8(1):e53466. PubMed ID: 23326436
[TBL] [Abstract][Full Text] [Related]
2. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
3. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
[TBL] [Abstract][Full Text] [Related]
5. Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
Javaid A; Hasan R; Zafar A; Chaudry MA; Qayyum S; Qadeer E; Shaheen Z; Agha N; Rizvi N; Afridi MZ; Chima MK; Khan AR; Ghafoor A; Khan S; Awan SR; Akhtar S; Choudry K; Iqbal ZH; Ansarie M; Ahmad N
Int J Tuberc Lung Dis; 2017 Mar; 21(3):303-308. PubMed ID: 28225340
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013.
Wu B; Zhang L; Liu Z; He H; Pan A; Wang F; Zhang M; Chen B; Lu Z; Chen S; Wang X
Glob Health Action; 2017; 10(1):1293925. PubMed ID: 28578621
[TBL] [Abstract][Full Text] [Related]
7. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
Varghese B; Al-Hajoj S
Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
[TBL] [Abstract][Full Text] [Related]
9. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
10. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
12. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
[TBL] [Abstract][Full Text] [Related]
13. From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
Stoffels K; Allix-Béguec C; Groenen G; Wanlin M; Berkvens D; Mathys V; Supply P; Fauville-Dufaux M
PLoS One; 2013; 8(5):e63128. PubMed ID: 23671662
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
Lee M; Han J; Kim YR; Kwak N; Kim JH; Park O; Shin S; Moon HS; Kim HJ; Jang MJ; Yim JJ
Int J Tuberc Lung Dis; 2019 Jul; 23(7):850-857. PubMed ID: 31439118
[No Abstract] [Full Text] [Related]
17. Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs.
Li N; Liao X; Chen L; Wang J; Liu M; Zhang H
Microb Drug Resist; 2015 Jun; 21(3):292-6. PubMed ID: 25599413
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India.
Datta BS; Hassan G; Kadri SM; Qureshi W; Kamili MA; Singh H; Manzoor A; Wani MA; Shamas-u-Din ; Thakur N
J Infect Dev Ctries; 2009 Nov; 4(1):19-23. PubMed ID: 20130374
[TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
[TBL] [Abstract][Full Text] [Related]
20. Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
Anastasakos V; Skouras V; Moschos C; Tsikrika S; Karabela S; Marinou I; Vogiatzakis E; Konstantinou K; Papavasiliou A; Kalomenidis I
Int J Tuberc Lung Dis; 2017 Mar; 21(3):309-313. PubMed ID: 28225341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
